Michael Rossi

President and Chief Executive Officer

Michael Rossi is President, Chief Executive Officer, and a member of the Board of Directors of Y-mAbs Therapeutics. Mr. Rossi has more than 30 years of radiopharmaceutical, drug development, commercialization, and people leadership experience on a global scale, most recently as President, Medical Group at Mirion Technologies. Before Mirion, he served as the Head of Radioligand Imaging for Advanced Accelerators Applications (AAA), a Novartis Company. Mr. Rossi also spent five years at Jubilant Pharma, where he served in several different roles, including President of Jubilant Radiopharma, and brings experience from GE Healthcare, Tyco Healthcare/Mallinckrodt and Syncor International. Mr. Rossi earned a Bachelor of Science in Pharmacy from the University of the Sciences in Philadelphia and holds an Authorized Nuclear Pharmacist Certification from Butler University. He has served on several boards of directors and remains a Licensed Pharmacist in the state of Pennsylvania.